Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Hyperimmune Plasma Treatment in Patients With COVID-19 Severe Infection

NCT04385043 is registered in ClinicalTrials.gov with University of Catanzaro as lead sponsor.

NCT NCT04385043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04385043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Hyperimmune Plasma Treatment in Patients With COVID-19 Severe Infection
Lead sponsor
University of Catanzaro
Phase
Phase 2/3
Overall status
Unknown status
Start date
May 1, 2020
Completion date
May 15, 2021
Enrollment
400 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19